Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection
08. Mai 2023 09:15 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce that Mountain Valley MD Inc....
Mountain Valley MD Announces Stock Option Grant
06. März 2023 20:10 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, March 06, 2023 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP), an early-stage biotech business centered around the...
Mountain Valley MD Announces Transition of Chief Medical Officer to Advisory Role
11. Januar 2023 23:32 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP), an early-stage biotech business centered around the...
Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting Shares. Common Shares Trading on CSE Unaffected
07. Dezember 2022 20:00 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) announces that it will redeem all issued and outstanding...
Mountain Valley MD Provides Business Update, Focus On Commercialization Phase
29. November 2022 09:00 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to provide a business update and details of...
Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology
13. September 2022 09:00 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the commencement of commercial...
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%
27. Juni 2022 09:00 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the successful completion of its...
Mountain Valley MD Holdings Provides Business Update
28. April 2022 08:55 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to provide a business update on its...
Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects
16. März 2022 09:00 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the appointment of Dr. Elizabeth...
Mountain Valley MD Holdings Announces Restricted Share Unit Plan, RSU Grant and Stock Option Grant
28. Januar 2022 21:36 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) announces the adoption of a restricted share unit plan...